(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SYNE-CHF

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SYNE-CHF

ST13

US500000097068213

Class

9, 42

Filing

97068213

Registration

6916219

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

12/06/2022

Trademark type

Word

Nice classes

9, 42

Filing date

10/11/2021

Registration date

12/06/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/06/2022

Last transaction

12/06/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

99

Owner location

Oxford, Oxfordshire, GB

Examiner

GREEN, ASHLEY ELIZABETH

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Sensyne Health Group Limited

Representatives

Robert B.G. Horowitz, Esq. BAKER & HOSTETLER LLP

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Recorded and downloadable computer software for use by the healthcare and life sciences business sectors for analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms

Class 42

Designing and developing computer software containing algorithms for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment; Software as a Service (SAAS) services in the form of computer software for use by the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data in order to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment through the use of algorithms; Algorithms as a service (AAAS)on-linenon-downloadable software containing algorithms from a cloud-based platform for the design of computer software and computer programming for third-parties in the healthcare and life sciences business sectors for the purpose of analyzing patient and clinical trial data to support pharmaceutical research and development and to improve direct patient care by providing predictive models to aid physicians in stratifying patients and making appropriate medical interventions for their treatment

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/06/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/20/2022

PUBO

PUBLISHED FOR OPPOSITION

09/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/31/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/17/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

08/16/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/16/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

08/16/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/16/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/08/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/08/2022

ALIE

ASSIGNED TO LIE

07/07/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

06/22/2022

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

05/26/2022

GNSI

INQUIRY TO SUSPENSION E-MAILED

05/26/2022

CNSI

SUSPENSION INQUIRY WRITTEN

05/26/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/26/2021

GNSL

LETTER OF SUSPENSION E-MAILED

11/26/2021

CNSL

SUSPENSION LETTER WRITTEN

11/26/2021

DOCK

ASSIGNED TO EXAMINER

11/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/02/2021

NWAP

NEW APPLICATION ENTERED

10/14/2021

Continuous trademark protection

Get notified about every new filing that threatens SYNE-CHF or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.